(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 18.61% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.69%.
Glaukos's revenue in 2026 is $612,839,000.On average, 16 Wall Street analysts forecast GKOS's revenue for 2026 to be $37,887,742,093, with the lowest GKOS revenue forecast at $36,127,661,413, and the highest GKOS revenue forecast at $39,223,728,266. On average, 16 Wall Street analysts forecast GKOS's revenue for 2027 to be $47,367,050,608, with the lowest GKOS revenue forecast at $41,844,384,587, and the highest GKOS revenue forecast at $51,081,269,121.
In 2028, GKOS is forecast to generate $61,166,342,669 in revenue, with the lowest revenue forecast at $48,093,142,872 and the highest revenue forecast at $71,724,467,392.